NEW YORK, April 7, 2017 /PRNewswire/ --
Stock-Callers.com directs investors' attention to the Health Care Plans industry, which includes companies that offer health
benefit plans to employers and individuals who require long-term care or specialty benefits, along with point-of-service plans,
traditional indemnity plans, and other hybrid plans. Equities in today's lineup are: CVS Health Corp. (NYSE: CVS), Express
Scripts Holding Co. (NASDAQ: ESRX), UnitedHealth Group Inc. (NYSE: UNH), and Aetna Inc. (NYSE: AET). Learn more about these
stocks by downloading their comprehensive and free reports at:
http://stock-callers.com/registration
CVS Health
On Thursday, shares in Woonsocket, Rhode Island headquartered CVS Health Corp. saw a slight
drop of 0.03%, ending the day at $77.01 with a total trading volume of 6.33 million shares. The
stock is trading below its 50-day moving average by 2.57%. Shares of the Company, which together with its subsidiaries, provides
integrated pharmacy health care services, have a Relative Strength Index (RSI) of 30.79.
On April 05 th, 2017, CVS Health announced that it was recognized by Billion Dollar
Roundtable, a top-level corporate advocacy organization that promotes supply-chain diversity excellence, for reaching its goal of
spending over $1 billion with diverse suppliers. CVS Health joins the ranks as one of 26 major
US-based corporations that provide thought leadership and solutions-driven exploration of key issues in supplier diversity. CVS
complete research report is just a click away and free at:
http://stock-callers.com/registration/?symbol=CVS
Express Scripts
Shares in Saint Louis, Missouri headquartered Express Scripts Holding Co. ended the day 0.42%
lower at $65.79. A total volume of 4.97 million shares was traded, which was above their three
months average volume of 4.39 million shares. The stock is trading below its 50-day moving average by 2.96%. Furthermore, shares
of Express Scripts, which operates as a pharmacy benefit management company in the US, Canada,
and Europe, have an RSI of 47.24.
On March 15th, 2017, research firm Wells Fargo downgraded the Company's stock rating from
'Market Perform' to 'Underperform'.
On April 04 th, 2017, Express Scripts announced that it lowered prescription drug
spending for workers' compensation payers by 7.6% in 2016, according to the 11th edition of the Company's Workers'
Compensation Drug Trend Report. The complimentary report on ESRX can be downloaded at:
http://stock-callers.com/registration/?symbol=ESRX
UnitedHealth
At the close of trading on Thursday, shares in Minnetonka, Minnesota-based UnitedHealth Group
Inc. finished 0.02% lower at $165.34 with a total trading volume of 2.92 million shares. The stock
has advanced 2.33% over the previous three months and 3.70% on an YTD basis. The Company's shares are trading above their 50-day
and 200-day moving averages by 0.58% and 10.46%, respectively. Additionally, shares of UnitedHealth, which operates as a
diversified health and well-being company in the US, have an RSI of 49.46.
On March 22 nd, 2017, UnitedHealth announced that the Company will release its Q1
2017 financial results on Tuesday, April 18 th, 2017, before the market opens. The
Company will also host a teleconference at 8:45 a.m. ET on the same day to discuss the results with
analysts and investors. The call will be webcast on the Investors page of the Company's website.
On April 05 th, 2017, research firm Deutsche Bank initiated a 'Buy' rating on the
Company's stock, with a target price of $183 per share. Sign up for your complimentary research
report on UNH at:
http://stock-callers.com/registration/?symbol=UNH
Aetna
Hartford, Connecticut-based Aetna Inc.'s shares recorded a trading volume of 2.29 million
shares at the end of yesterday's session. The stock closed the day 1.23% higher at $128.84. The
Company's shares have advanced 3.69% in the last three months and 4.11% on an YTD basis. The stock is trading above its 50-day
and 200-day moving averages by 1.68% and 6.86%, respectively. Additionally, shares of Aetna, which operates as a health care
benefits company in the US, have an RSI of 53.97.
On April 05 th, 2017, research firm Deutsche Bank initiated a 'Hold' rating on the
Company's stock, with a target price of $135 per share. Get free access to your research report on
AET at:
http://stock-callers.com/registration/?symbol=AET
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES :
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a
third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on
analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed
any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently
reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or
interfere in the application of such procedures by the third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or
the Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing
of the information, or (2) warrant any results from use of the information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers
in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you ' re
a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between
09:30 EDT to 16:00 EDT from Monday to Friday
at:
Email: info@stock-callers.com
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA